Deng, R. et al. Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis. Sci. Transl. Med. 16, eadh9751 (2024).
Zhou, D. et al. Intra-articular nanodrug delivery strategies for treating osteoarthritis. Drug Discov. Today 28, 103482 (2022).
Jones, I. A., Togashi, R., Wilson, M. L., Heckmann, N. & Vangsness, C. T. Jr Intra-articular treatment options for knee osteoarthritis. Nat. Rev. Rheumatol. 15, 77–90 (2019).
Bedingfield, S. K. et al. Amelioration of post-traumatic osteoarthritis via nanoparticle depots delivering small interfering RNA to damaged cartilage. Nat. Biomed. Eng. 5, 1069–1083 (2021).
James, S. L. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789–1858 (2018).
Hunter, D. J., March, L. & Chew, M. Osteoarthritis in 2020 and beyond: a Lancet Commission. Lancet 396, 1711–1712 (2020).
Kim, H. et al. The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities. Ther. Adv. Musculoskel. 14, 1759720X221085952 (2022).
Lindström, E. et al. Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711. J. Transl. Med. 16, 1–14 (2018).
Mancipe Castro, L., Garcia, A. & Guldberg, R. Biomaterial strategies for improved intra-articular drug delivery. J. Biomed. Mater. Res. A 109, 426–436 (2021).
Sterner, B. et al. The effect of polymer size and charge of molecules on permeation through synovial membrane and accumulation in hyaline articular cartilage. Eur. J. Pharm. Biopharm. 101, 126–136 (2016).
Rahimi, M., Charmi, G., Matyjaszewski, K., Banquy, X. & Pietrasik, J. Recent developments in natural and synthetic polymeric drug delivery systems used for the treatment of osteoarthritis. Acta Biomater. 123, 31–50 (2021).
Rothenfluh, D., Bermudez, H., O’Neil, C. & Hubbell, J. Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat. Mater. 7, 248–254 (2008).
Ji, M. et al. Precise targeting of miR-141/200c cluster in chondrocytes attenuates osteoarthritis development. Ann. Rheum. Dis. 80, 356–366 (2020).
Chen, J. et al. A quick and innovative pipeline for producing chondrocyte-homing peptide-modified extracellular vesicles by three-dimensional dynamic culture of hADSCs spheroids to modulate the fate of remaining ear chondrocytes in the M1 macrophage-infiltrated microenvironment. J. Nanobiotechnol. 22, 300 (2024).
Zhou, D. et al. MMP13-targeted siRNA-loaded micelles for diagnosis and treatment of posttraumatic osteoarthritis. Bioact. Mater. 37, 378–392 (2024).
Smith, A. E. & Helenius, A. How viruses enter animal cells. Sci. Adv. 304, 237–242 (2004).
Grove, J. & Marsh, M. The cell biology of receptor-mediated virus entry. J. Cell Biol. 195, 1071–1082 (2011).
Weissenhorn, W. et al. Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol. 16, 3–9 (1999).
Von der Mark, K. et al. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum. 35, 806–811 (1992).
Knudson, W. & Loeser, R. CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell. Mol. Life Sci. 59, 36–44 (2002).
Li, H., Wang, D., Yuan, Y. & Min, J. New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis. Arthritis Res. Ther. 19, 248 (2017).
Dissanayake, S., Denny, W. A., Gamage, S. & Sarojini, V. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. J. Control. Release 250, 62–76 (2017).
Olson, E. S. et al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc. Natl Acad. Sci. USA 107, 4311–4316 (2010).
Jiang, T. et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc. Natl Acad. Sci. USA 101, 17867–17872 (2004).
Zhang, H. et al. Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression. Sci. Adv. 9, eabo7868 (2023).
Schipani, E. et al. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev. 15, 2865–2876 (2001).
Kim, J.-w., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177–185 (2006).
Stegen, S. et al. HIF-1α metabolically controls collagen synthesis and modification in chondrocytes. Nature 565, 511–515 (2019).
Bouaziz, W. et al. Interaction of HIF1alpha and beta-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice. Proc. Natl Acad. Sci. USA 113, 5453–5458 (2016).
Ummarino, D. Hypoxia protects against cartilage loss by regulating Wnt signalling. Nat. Rev. Rheumatol. 12, 315–315 (2016).
Philip, M. et al. Metabolic studies of hypoxia-inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control. Drug Test. Anal. 13, 794–816 (2021).
Stoddart, J. C., Dandridge, O., Garner, A., Cobb, J. & van Arkel, R. J. The compartmental distribution of knee osteoarthritis—a systematic review and meta-analysis. Osteoarthr. Cartil. 29, 445–455 (2021).
Wang, Q. et al. Dysregulated integrin αVβ3 and CD47 signaling promotes joint inflammation, cartilage breakdown, and progression of osteoarthritis. JCI Insight 4, e128616 (2019).
Gao, J. et al. Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs. Trends Pharmacol. Sci. 43, 171–187 (2022).
Shimomura, S. et al. Mechanical stimulation of chondrocytes regulates HIF-1α under hypoxic conditions. Tissue Cell 71, 101574 (2021).
Adesida, A. B. et al. Human meniscus cells express hypoxia inducible factor-1α and increased SOX9 in response to low oxygen tension in cell aggregate culture. Arthritis Res. Ther. 9, R69 (2007).
Yu, Q. et al. Efficient siRNA transfer to knockdown a placenta specific lncRNA using RGD-modified nano-liposome: a new preeclampsia-like mouse model. Int. J. Pharm. 546, 115–124 (2018).
Mao, X. et al. iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells. Nanomedicine 10, 2677–2695 (2015).
Wei, Y. et al. Phospholipase A2 inhibitor-loaded micellar nanoparticles attenuate inflammation and mitigate osteoarthritis progression. Sci. Adv. 7, eabe6374 (2021).
Van den Borne, M. et al. International Cartilage Repair Society (ICRS) and Oswestry macroscopic cartilage evaluation scores validated for use in autologous chondrocyte implantation (ACI) and microfracture. Osteoarthr. Cartil. 15, 1397–1402 (2007).
Pritzker, K. P. et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr. Cartil. 14, 13–29 (2006).
Little, C. B. et al. The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in sheep and goats. Osteoarthr. Cartil. 18, S80–S92 (2010).
Oláh, T. et al. Topographic modeling of early human osteoarthritis in sheep. Sci. Transl. Med. 11, eaax6775 (2019).
